Stimunity is a startup company directed by Sylvain Carlioz, CEO, and located in Paris. The company exploits an exclusive license on patents from Institut Curie, INSERM and Oxford University on a biological therapeutic drug to activate the immunomodulatory STING pathway.
PI: Dr. N. Manel
Early Stage Researcher: Adriana Loverre
Websites:
https://stimunity.com/
https://science.institut-curie.org/research/integrated-biology/u932-immunity-and-cancer/team-manel/
